FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) met on May 22, 2025, to discuss and make recommendations on the selection of the 2025-2026 Formula for COVID-19 vaccines for use in the United States beginning in the fall of 2025.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/qWxYdrG
No comments:
Post a Comment